Human P450PCN1: Sequence, Chromosome Localization, and Direct Evidence through cDNA Expression That P450PCN1 Is Nifedipine Oxidase

DNA

Volumn 7, Issue 2, 1988, Pages 79-86

  Gonzalez, Frank J ^a   Umeno, Morio ^a   Gelboin, Harry V ^a   Schmid, Balthazar J ^b   Idle, Jeffrey R ^b   Mcbride, O Wesley ^a   Hardwick, James P ^c   Meyer, Urs A ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ARGONNE NATIONAL LABORATORY   (United States)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOCHROME P450; NIFEDIPINE; RADIOISOTOPE;

CELL CULTURE; CHROMOSOME 7; CYTOLOGY; GENE ASSIGNMENT; GENE LOCATION; GENE STRUCTURE; GENETIC ENGINEERING; HEREDITY; HUMAN; HUMAN CELL; LIVER; NORMAL HUMAN; NORMAL VALUE; NUCLEOTIDE SEQUENCE;

AMINO ACID SEQUENCE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 7; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION REGULATION; HUMAN; MICROSOMES, LIVER; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; NIFEDIPINE; OXIDATION-REDUCTION; SEQUENCE HOMOLOGY, NUCLEIC ACID; SUPPORT, NON-U.S. GOV'T;

EID: 0023858226     PISSN: 01980238     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.1988.7.79     Document Type: Article

References (28)

1. Adesnik, M., and Atchison, M. (1986). Genes for cytochrome P-450 and their regulation. Crit. Rev. Biochem. 19, 247–305.
2. Atchison, M., and Adesnik, M. (1986). Gene conversion in a cytochrome P-450 gene family. Proc. Natl. Acad. Sci. USA 83, 2300–2304.
3. Beaune, P.H., Umbenhauer, D.R., Bork, R.W., Lloyd, R.S., and Guengerich, F.P. (1986). Isolation and sequence determination of a cDNA clone related to human cytochrome P450 nifedipine oxidase. Proc. Natl. Acad. Sci. USA 83, 8064–8068.
4. Deininger, P.L. (1983). Random subcloning of sonicated DNA: Application to shotgun DNA sequence analysis. Anal. Biochem. 129, 216–223.
5. Distlerath, L.M., Reilly, P.E.B., Martin, M.V., Davis, G.G., Wilkinson, G.R., and Guengerich, F.P. (1985). Purification and characterization of the human liver cytochrome P-450 involved in debrisoquine 4-hydroxyla-tion and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism. J. Biol. Chem. 260, 9057–9067.
6. Gonzalez, F.J., Nebert, D.W., Hardwick, J.P., and Kasper, C.B. (1985). Complete cDNA and protein sequence of a pregnenolone 16 alpha carbonitrile-induced cytochrome P450: A representative of a new gene family. J. Biol. Chem. 260, 7435–7441.
7. Gonzalez, F.J., Song, B.J., and Hardwick, J.P. (1986). Pregnenolone 16 alpha-carbonitrile-inducible P450 gene family: Gene conversion and differential regulation. Mol. Cell. Biol. 6, 2969–2976.
8. Guengerich, F.P., Martin, M.V., Beaune, P.H., Kremers, P., Wolff, T., and Waxman, D.J. (1986). Characterization of rat and human liver microsomal cytochrome P450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J. Biol. Chem. 261, 5051–5060.
9. Gut, J., Catin, T., Dayer, P., Kronbach, T., Zan-Ger., U., and Meyer, V.A. (1986). Debrisoquine/sparteine-type polymorphism of drug oxidation: Purification and characterization of two functionally different human liver cytochrome P-450 isozymes involved in impaired hydroxylation of the prototype substrate bufuralol. J. Biol. Chem. 261, 11734–11743.
10. Hardwick, J.P., Gonzalez, F.J., and Kasper, B.C. (1983). Cloning of DNA complementary to cytochrome P-450 induced by pregnenolone 16 alpha-carbonitrile: Characterization of its mRNA, gene and induction response. J. Biol. Chem. 258, 10182–10186.
11. Idle, J.R., and Smith, R.L. (1979). Polymorphisms of oxidation at carbon centers of drugs and their clinical significance. Drug Metab. Rev. 9, 301–317.
12. Idle, J.R., and Smith, R.L. (1984). The debrisoquine hydroxylation gene: A gene of multiple consequences. Proc. Second World Conference on Clinical Pharmacology and Therapeutics, pp. 148–164.
13. Kleinbloesem, C.H., van Brummelen, P., Faber, H., Danhof, M., Vermeulen, N.P.E., and Breimer, D.D. (1984). Variability in nifedipine pharmacokinetics and dynamics: A new oxidation polymorphism in man. Biochem. Pharmacol. 33, 3721–3724.
14. Luthman, H., and Magnusson, G. (1983). High efficiency POLYOMA DNA transfection of chloroquine treated cells. Nucleic Acids Res. 11, 1295.
15. Mcbride, O.W., Battey, J., Hollis, G.F., Swan, D.C., Siebenlist, U., and Leder, P. (1982a). Localization of human variable and constant region immunoglobulin heavy chain genes on subtelomeric band q32 of chromosome 14. Nucleic Acids Res. 10, 8155–8170.
16. Mcbride, O.W., Hieter, P.A., Hollis, G.F., Swan, D.C., Otey, M.C., and Leder, P. (1982). Chromosomal localization of human kappa and lambda immunoglobulin light chain constant region genes. J. Exp. Med. 155, 1480–1490.
17. Mcbride, O.W., Swan, D.C., Santos, E., Barbacid, M., Tronick, S.R., and Aaronson, S.A. (1982c). Localization of the normal alíele of T4 human bladder carcinoma oncogene to chromosome 11. Nature 300, 773–774.
18. Mcbride, O.W., Merry, D., and Givol, D. (1986). The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17pl3). Proc. Natl. Acad. Sci. USA 83, 130–134.
19. Molowa, D.T., Schuetz, E.G., Wrighton, S.A., Wat-Kins, P.B., Kremers, P., Mendez-Picon, G., Parker, G.A., and Guzelian, P.S. (1986). Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver. Proc. Natl. Acad. Sci. USA 83, 5311–5315.
20. Nebert, D.W., and Gonzalez, F.J. (1987). P450 genes: Structure, evolution and regulation. Annu. Rev. Biochem. 56, 945–993.
21. Sanger, F., Nicklen, S., and Coulsen, A.R. (1977). DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463–5467.
22. Schmid, B.J., Perry, H.E., and Idle, J.R. (1987). Determination of nifedipine and its three principal metabolites in plasma and urine by automated electronecapture capillary gas chromatography. J. Chromatogr. Biomed. Appli. (in press).
23. Shimada, T., Misono, K.S., and Guengerich, F.R. (1986). Human liver microsomal cytochrome P-450 mepheny-toin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism: Purification and characterization of two similar forms involved in the reaction. J. Biol. Chem. 261, 909–921.
24. Song, B.J., Gelboin, H.V., Park, S.S., Yang, C.S., and Gonzalez, F.J. (1986). Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P-450s: Transcriptional and post-transcriptional regulation of the rat enzyme. J. Biol. Chem. 261, 16689–16697.
25. Towbin, H., Staehlin, T., and Gordin, J. (1979). Elec-trophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350–4355.
26. Watson, C.J., and Jackson, F.J. (1985). An alternative procedure for the synthesis of double-stranded cDNA for the cloning in phage and plasmid vectors. In DNA Cloning, vol. 1, D.M. Glover, Ed. (IRL, Washington, DC) pp. 79–88.
27. White, R., Woodward, S., Leppert, M., O'Connell, P., Nakamura, Y., Hoff, M., Herbst, J., Jean-Mark, L., Dean, M., and Vande Would, G. (1985). A closely linked genetic marker for cystic fibrosis. Nature 318, 382–384.
28. Wong, G.G., Witek, J.S., Temple, P.A., Wilkens, K.M., Leary, A.C., Luxenberg, D.P., Jones, S.S., Brown, E.L., Kay, R.M., Orr, E.C., Shoemaker, C., Golde, D.W., Kaufman, R.J., Hewick, R.M., Wang, E.A., and Clark, S.C. (1985). Human GM-CSF: Molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science 228, 810–815.